1/7/25 17:20 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S | -116 | 12.18 | 0 | -10 | -10 | 88 | D | | | | | | | | | | | | | | |
1/5/24 16:50 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S | -172 | 29.46 | 0 | -6 | -10 | 54 | D | | | | | | | | | | | | | | |
1/3/24 17:34 | 1/1/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 3 | 6 | 60 | D | | | | | | | | | | | | | | |
1/6/23 17:26 | 1/4/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S | -96 | 37.21 | 0 | -3 | -9 | 26 | D | | | | | | | | | | | | | | |
1/4/23 20:33 | 1/1/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 3 | 13 | 28 | D | | | | | | | | | | | | | | |
3/3/22 20:00 | 1/1/22 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S.d | -118 | 112.24 | 0 | -1 | -4 | 25 | D | | | | | | | | | | | | | | |
3/3/22 20:00 | 1/1/22 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 3 | 15 | 25 | D | | | | | | | | | | | | | | |
11/9/21 18:08 | 11/5/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 30 | 12.62 | 0 | 2 | 38 | 9 | D | | | | | | | | | | | | | | |
11/9/21 18:08 | 11/5/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S.d | -319 | 132.72 | 0 | -2 | -22 | 9 | D | | | | | | | | | | | | | | |
10/15/21 19:02 | 10/14/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S.d | -308 | 128.44 | 0 | -2 | -22 | 9 | D | | | | | | | | | | | | | | |
10/15/21 19:02 | 10/14/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 30 | 12.62 | 0 | 2 | 38 | 9 | D | | | | | | | | | | | | | | |
9/27/21 16:15 | 9/24/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 100 | 12.62 | 0 | 8 | 999% | 9 | D | | | | | | | | | | | | | | |
9/23/21 17:48 | 9/21/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S.d | -360 | 149.81 | 0 | -2 | -75 | 1 | D | | | | | | | | | | | | | | |
9/23/21 17:48 | 9/21/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 30 | 12.62 | 0 | 2 | | 1 | D | | | | | | | | | | | | | | |
9/1/21 19:32 | 8/30/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S.d | -379 | 158.04 | 0 | -2 | -75 | 1 | D | | | | | | | | | | | | | | |
9/1/21 19:32 | 8/30/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 30 | 12.62 | 0 | 2 | | 1 | D | | | | | | | | | | | | | | |
8/11/21 16:50 | 8/9/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 30 | 12.62 | 0 | 2 | | 1 | D | | | | | | | | | | | | | | |
8/11/21 16:50 | 8/9/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S.d | -394 | 164.05 | 0 | -2 | -75 | 1 | D | | | | | | | | | | | | | | |